---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "69YGOJAv9/xEUtGewvD4c7wLWEsv0wfb1N1X/vGXjzpRPJWiu2sKgrTZoBR79SsnmgVP0/VoluThJ0bZHeoTzlkaEVQ+hRdnoCNZDBIwlUlqaJwyYwyHXMI7PzisnXNSaMquAR/kAf4ic+WH2UNOUPQvcH2/9J1lNouv7S0YBwgXy81+c8/BDHClkSzcV4npnqeUDhbBrFYixqyqlWlF1zq+4eWn18bksLci8AMO4PrzxOMqu1snBD5OS4r1z6T+GD2K536eHQStN35fjKBBM6LpKsRtduoQYkB9NAw5Tvx6tBG9cj0Wte6pR7jNbHNJ;1jECVdC3RKRQDRq18ymtNQ=="
---

